annual net income:
-$69.92M+$2.93M(+4.02%)Summary
- As of today (August 20, 2025), ABUS annual net profit is -$69.92 million, with the most recent change of +$2.93 million (+4.02%) on December 31, 2024.
- During the last 3 years, ABUS annual net income has risen by +$6.33 million (+8.30%).
- ABUS annual net income is now -334.60% below its all-time high of $29.80 million, reached on December 31, 2012.
Performance
ABUS Net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly net income:
$2.52M+$27.05M(+110.29%)Summary
- As of today (August 20, 2025), ABUS quarterly net profit is $2.52 million, with the most recent change of +$27.05 million (+110.29%) on June 30, 2025.
- Over the past year, ABUS quarterly net income has increased by +$22.32 million (+112.74%).
- ABUS quarterly net income is now -93.47% below its all-time high of $38.65 million, reached on December 31, 2012.
Performance
ABUS quarterly net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM net income:
-$54.25M+$22.32M(+29.15%)Summary
- As of today (August 20, 2025), ABUS TTM net profit is -$54.25 million, with the most recent change of +$22.32 million (+29.15%) on June 30, 2025.
- Over the past year, ABUS TTM net income has increased by +$22.84 million (+29.62%).
- ABUS TTM net income is now -276.72% below its all-time high of $30.70 million, reached on March 31, 2013.
Performance
ABUS TTM net income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Net income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
ABUS Net income Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +4.0% | +112.7% | +29.6% |
| 3 y3 years | +8.3% | +117.8% | +23.0% |
| 5 y5 years | +54.5% | +117.9% | +59.8% |
ABUS Net income Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -0.7% | +8.3% | at high | +110.3% | at high | +29.6% |
| 5 y | 5-year | -9.7% | +54.5% | at high | +110.3% | at high | +59.8% |
| alltime | all time | -334.6% | +81.8% | -93.5% | +101.2% | -276.7% | +86.0% |
ABUS Net income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $2.52M(-110.3%) | -$54.25M(-29.1%) |
| Mar 2025 | - | -$24.53M(+95.7%) | -$76.57M(+9.5%) |
| Dec 2024 | -$69.92M(-4.0%) | -$12.53M(-36.4%) | -$69.92M(-8.8%) |
| Sep 2024 | - | -$19.72M(-0.4%) | -$76.70M(-0.5%) |
| Jun 2024 | - | -$19.80M(+10.7%) | -$77.09M(+3.6%) |
| Mar 2024 | - | -$17.88M(-7.4%) | -$74.39M(+2.1%) |
| Dec 2023 | -$72.85M(+4.9%) | -$19.31M(-3.9%) | -$72.85M(-3.5%) |
| Sep 2023 | - | -$20.10M(+17.6%) | -$75.47M(+3.5%) |
| Jun 2023 | - | -$17.09M(+4.6%) | -$72.93M(+4.1%) |
| Mar 2023 | - | -$16.34M(-25.5%) | -$70.03M(+0.8%) |
| Dec 2022 | -$69.46M(-8.9%) | -$21.93M(+24.8%) | -$69.46M(+0.9%) |
| Sep 2022 | - | -$17.57M(+23.8%) | -$68.84M(-2.3%) |
| Jun 2022 | - | -$14.19M(-10.0%) | -$70.44M(-6.9%) |
| Mar 2022 | - | -$15.77M(-26.1%) | -$75.63M(-0.8%) |
| Dec 2021 | -$76.25M(+19.6%) | -$21.32M(+11.3%) | -$76.25M(+5.9%) |
| Sep 2021 | - | -$19.16M(-1.2%) | -$71.97M(+0.6%) |
| Jun 2021 | - | -$19.39M(+18.4%) | -$71.56M(+8.0%) |
| Mar 2021 | - | -$16.38M(-3.9%) | -$66.27M(+4.0%) |
| Dec 2020 | -$63.74M(-58.5%) | -$17.04M(-9.1%) | -$63.74M(-10.7%) |
| Sep 2020 | - | -$18.75M(+33.1%) | -$71.36M(-47.2%) |
| Jun 2020 | - | -$14.09M(+1.6%) | -$135.10M(-6.4%) |
| Mar 2020 | - | -$13.86M(-43.8%) | -$144.33M(-6.1%) |
| Dec 2019 | -$153.72M(+169.4%) | -$24.65M(-70.1%) | -$153.72M(+4.3%) |
| Sep 2019 | - | -$82.50M(+253.9%) | -$147.32M(+65.0%) |
| Jun 2019 | - | -$23.32M(+0.3%) | -$89.29M(+42.0%) |
| Mar 2019 | - | -$23.25M(+27.4%) | -$62.88M(+10.2%) |
| Dec 2018 | -$57.06M(-32.4%) | -$18.25M(-25.4%) | -$57.06M(-23.7%) |
| Sep 2018 | - | -$24.47M(-891.8%) | -$74.74M(+20.8%) |
| Jun 2018 | - | $3.09M(-117.7%) | -$61.87M(-25.7%) |
| Mar 2018 | - | -$17.43M(-51.5%) | -$83.22M(-1.4%) |
| Dec 2017 | -$84.41M(-78.0%) | -$35.93M(+209.8%) | -$84.41M(-68.4%) |
| Sep 2017 | - | -$11.60M(-36.5%) | -$267.18M(-2.9%) |
| Jun 2017 | - | -$18.25M(-2.0%) | -$275.17M(-28.9%) |
| Mar 2017 | - | -$18.63M(-91.5%) | -$386.92M(+0.7%) |
| Dec 2016 | -$384.16M(+528.5%) | -$218.69M(+1016.1%) | -$384.16M(+125.0%) |
| Sep 2016 | - | -$19.59M(-84.9%) | -$170.73M(-5.2%) |
| Jun 2016 | - | -$130.00M(+718.9%) | -$180.12M(+177.1%) |
| Mar 2016 | - | -$15.87M(+201.6%) | -$65.01M(+6.4%) |
| Dec 2015 | -$61.12M(+57.4%) | -$5.26M(-81.8%) | -$61.12M(-1.5%) |
| Sep 2015 | - | -$28.98M(+94.7%) | -$62.02M(+48.9%) |
| Jun 2015 | - | -$14.89M(+24.2%) | -$41.65M(+26.8%) |
| Mar 2015 | - | -$11.99M(+94.4%) | -$32.84M(-15.4%) |
| Dec 2014 | -$38.84M(+176.1%) | -$6.17M(-28.3%) | -$38.84M(+10.1%) |
| Sep 2014 | - | -$8.60M(+41.5%) | -$35.27M(+8.5%) |
| Jun 2014 | - | -$6.08M(-66.2%) | -$32.52M(+10.3%) |
| Mar 2014 | - | -$17.98M(+591.9%) | -$29.47M(+109.2%) |
| Dec 2013 | -$14.06M(-147.2%) | -$2.60M(-55.6%) | -$14.09M(-151.9%) |
| Sep 2013 | - | -$5.85M(+93.0%) | $27.17M(-8.1%) |
| Jun 2013 | - | -$3.03M(+16.7%) | $29.57M(-3.7%) |
| Mar 2013 | - | -$2.60M(-106.7%) | $30.70M(+1.8%) |
| Dec 2012 | $29.80M(-396.7%) | $38.65M(-1220.2%) | $30.14M(-392.5%) |
| Sep 2012 | - | -$3.45M(+81.3%) | -$10.31M(+23.4%) |
| Jun 2012 | - | -$1.90M(-39.7%) | -$8.35M(-17.3%) |
| Mar 2012 | - | -$3.16M(+75.7%) | -$10.10M(+0.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | -$10.04M(-16.7%) | -$1.80M(+19.9%) | -$10.08M(+7.5%) |
| Sep 2011 | - | -$1.50M(-58.9%) | -$9.38M(-10.4%) |
| Jun 2011 | - | -$3.65M(+16.1%) | -$10.46M(-4.1%) |
| Mar 2011 | - | -$3.14M(+188.4%) | -$10.91M(-9.2%) |
| Dec 2010 | -$12.05M(+40.8%) | -$1.09M(-57.8%) | -$12.01M(-10.3%) |
| Sep 2010 | - | -$2.58M(-37.0%) | -$13.39M(+0.0%) |
| Jun 2010 | - | -$4.09M(-3.6%) | -$13.39M(+19.3%) |
| Mar 2010 | - | -$4.25M(+71.9%) | -$11.22M(+28.3%) |
| Dec 2009 | -$8.56M(-35.9%) | -$2.47M(-4.1%) | -$8.75M(+0.3%) |
| Sep 2009 | - | -$2.58M(+33.7%) | -$8.72M(-26.9%) |
| Jun 2009 | - | -$1.93M(+8.9%) | -$11.93M(-19.4%) |
| Mar 2009 | - | -$1.77M(-27.6%) | -$14.79M(+9.9%) |
| Dec 2008 | -$13.36M(+460.9%) | -$2.45M(-57.7%) | -$13.46M(+26.5%) |
| Sep 2008 | - | -$5.78M(+20.7%) | -$10.64M(+211.3%) |
| Jun 2008 | - | -$4.79M(+1009.9%) | -$3.42M(+3.4%) |
| Mar 2008 | - | -$431.90K(-217.1%) | -$3.30M(+45.9%) |
| Dec 2007 | -$2.38M(-112.8%) | $368.80K(-74.4%) | -$2.27M(-8.8%) |
| Sep 2007 | - | $1.44M(-130.7%) | -$2.48M(+256.1%) |
| Jun 2007 | - | -$4.68M(-870.7%) | -$697.50K(-103.0%) |
| Mar 2007 | - | $607.20K(+304.8%) | $22.88M(+21.1%) |
| Dec 2006 | $18.58M(-340.6%) | - | - |
| Dec 2006 | - | $150.00K(-95.3%) | $18.89M(+23.9%) |
| Sep 2006 | - | $3.23M(-82.9%) | $15.25M(+48.0%) |
| Jun 2006 | - | $18.89M(-658.9%) | $10.30M(-158.4%) |
| Mar 2006 | - | -$3.38M(-3.1%) | -$17.64M(+129.7%) |
| Dec 2005 | -$7.72M(-70.2%) | - | - |
| Dec 2005 | - | -$3.49M(+102.8%) | -$7.68M(-197.7%) |
| Sep 2005 | - | -$1.72M(-81.0%) | $7.86M(+40.4%) |
| Jun 2005 | - | -$9.05M(-237.6%) | $5.60M(-39.8%) |
| Mar 2005 | - | $6.58M(-45.4%) | $9.31M(-520.3%) |
| Dec 2004 | -$25.91M(-22.8%) | - | - |
| Dec 2004 | - | $12.06M(-402.8%) | -$2.22M(-90.6%) |
| Sep 2004 | - | -$3.98M(-25.5%) | -$23.66M(-13.2%) |
| Jun 2004 | - | -$5.35M(+8.2%) | -$27.27M(-8.5%) |
| Mar 2004 | - | -$4.94M(-47.3%) | -$29.79M(-4.0%) |
| Dec 2003 | -$33.55M(+1905.6%) | - | - |
| Dec 2003 | - | -$9.39M(+23.7%) | -$31.04M(+1.0%) |
| Sep 2003 | - | -$7.59M(-3.5%) | -$30.74M(+0.1%) |
| Jun 2003 | - | -$7.87M(+26.9%) | -$30.71M(+7.5%) |
| Mar 2003 | - | -$6.20M(-31.8%) | -$28.57M(+1.9%) |
| Dec 2002 | -$1.67M(-88.9%) | - | - |
| Dec 2002 | - | -$9.09M(+20.2%) | -$28.04M(+16.3%) |
| Sep 2002 | - | -$7.56M(+32.2%) | -$24.10M(+18.7%) |
| Jun 2002 | - | -$5.72M(+1.0%) | -$20.29M(+9.3%) |
| Mar 2002 | - | -$5.66M(+10.0%) | -$18.56M(+24.3%) |
| Dec 2001 | -$15.03M(+61.8%) | - | - |
| Dec 2001 | - | -$5.15M(+37.0%) | -$14.93M(+52.6%) |
| Sep 2001 | - | -$3.76M(-5.8%) | -$9.78M(+62.4%) |
| Jun 2001 | - | -$3.99M(+96.6%) | -$6.02M(+196.6%) |
| Mar 2001 | - | -$2.03M | -$2.03M |
| Dec 2000 | -$9.29M(+16.6%) | - | - |
| Dec 1999 | -$7.97M(-12.2%) | - | - |
| Dec 1998 | -$9.08M(+36.5%) | - | - |
| Dec 1997 | -$6.65M | - | - |
FAQ
- What is Arbutus Biopharma Corporation annual net profit?
- What is the all time high annual net income for Arbutus Biopharma Corporation?
- What is Arbutus Biopharma Corporation annual net income year-on-year change?
- What is Arbutus Biopharma Corporation quarterly net profit?
- What is the all time high quarterly net income for Arbutus Biopharma Corporation?
- What is Arbutus Biopharma Corporation quarterly net income year-on-year change?
- What is Arbutus Biopharma Corporation TTM net profit?
- What is the all time high TTM net income for Arbutus Biopharma Corporation?
- What is Arbutus Biopharma Corporation TTM net income year-on-year change?
What is Arbutus Biopharma Corporation annual net profit?
The current annual net income of ABUS is -$69.92M
What is the all time high annual net income for Arbutus Biopharma Corporation?
Arbutus Biopharma Corporation all-time high annual net profit is $29.80M
What is Arbutus Biopharma Corporation annual net income year-on-year change?
Over the past year, ABUS annual net profit has changed by +$2.93M (+4.02%)
What is Arbutus Biopharma Corporation quarterly net profit?
The current quarterly net income of ABUS is $2.52M
What is the all time high quarterly net income for Arbutus Biopharma Corporation?
Arbutus Biopharma Corporation all-time high quarterly net profit is $38.65M
What is Arbutus Biopharma Corporation quarterly net income year-on-year change?
Over the past year, ABUS quarterly net profit has changed by +$22.32M (+112.74%)
What is Arbutus Biopharma Corporation TTM net profit?
The current TTM net income of ABUS is -$54.25M
What is the all time high TTM net income for Arbutus Biopharma Corporation?
Arbutus Biopharma Corporation all-time high TTM net profit is $30.70M
What is Arbutus Biopharma Corporation TTM net income year-on-year change?
Over the past year, ABUS TTM net profit has changed by +$22.84M (+29.62%)